United Therapeutics Corporation (UTHR) Net margin 2016–2025
United Therapeutics Corporation (UTHR) net profit margin by fiscal year — reported net income divided by reported revenue.
41.9%FY2025 · since FY2016: 44.6% → 41.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 41.9% | +0.4 pp |
| FY2024 | 41.5% | -0.8 pp |
| FY2023 | 42.3% | +4.8 pp |
| FY2022 | 37.6% | +9.3 pp |
| FY2021 | 28.2% | -6.5 pp |
| FY2020 | 34.7% | +41.9 pp |
| FY2019 | -7.2% | -43.4 pp |
| FY2018 | 36.2% | +12.0 pp |
| FY2017 | 24.2% | -20.4 pp |
| FY2016 | 44.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More UTHR financial trends
UTHR RevenueUTHR Net incomeUTHR Gross profitUTHR Gross marginUTHR Operating incomeUTHR Operating marginUTHR Operating cash flowUTHR Free cash flowUTHR Capital expendituresUTHR Return on equityUTHR Stock buybacksUTHR Dividends paidUTHR Total assetsUTHR Total liabilitiesUTHR Shareholders’ equityUTHR overview →